Figure 4.
(a) CBPS-adjusted transplant-free survival by HRS reversal status for terlipressin vs midodrine plus octreotide. (b) CBPS-adjusted transplant-free survival by HRS reversal status regardless of treatment cohort. Sample sizes for adjusted results represent effective sample size after using CBPS reweighting. CBPS, covariate balancing propensity scoring; CI, confidence interval; HRS, hepatorenal syndrome.
